nach oben

Erschienen in:

08.08.2023 | Breast Oncology

Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions

verfasst von: Nicholas T. Champion, MD, Blaise Mooney, MD, Youngchul Kim, PhD, Junmin Whiting, PhD, Weihong Sun, MD, MS, John Kiluk, MD, Brian Czerniecki, MD, PhD, Susan Hoover, MD, Marie Catherine Lee, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

SmartClip^TM is a food and drug administration-approved, electromagnetic chip (EMC) localization system that provides three-dimensional navigation for the excision of soft tissue lesions. The purpose of this study was to analyze the accuracy and feasibility of EMC radiologic and surgical localization for benign and malignant breast lesions.

Patients and Methods

An institutional review board-approved, single institution, prospective study from October 2020 to September 2022 of 38 women undergoing breast conserving surgery with EMC localization of a single lesion > 5 mm on mammogram (MMG) or ultrasound (US) imaging. Surveys from performing breast radiologists and breast surgeons were collected after image-guided localization and surgical excision.

Results

Seventy-six survey responses from nine radiologists and four surgeons were received. The deployment needle and EMC were highly visible in 86.8% and 76.3% of procedures, respectively. There was no difficulty in deployment for 92.1% of procedures. The EMC was in the correct location on postdeployment MMG in 97.4% of cases. Three instances of EMC migration occurred, one 1 cm from target lesion. The targeted mass and EMC were within the surgical specimen in 97.4% of cases. On specimen radiograph, 39.5% of the EMCs were 0–1 mm from the center of the target lesion, 18.4% were within 2–4 mm, and 23.7% were within 5–10 mm. Mean operating room time for all cases was 65 min. One case required US to localize the target due to console malfunction.

Conclusion

There was successful EMC deployment by radiologists with accurate visualization and successful surgical excision in most cases. The EnVisio^TM SmartClip^TM system is a reproducible and accurate localization method for benign and malignant breast lesions.

Hall FM, Frank HA. Preoperative localization of nonpalpable breast lesions. AJR Am J Roentgenol. 1979;132(1):101–5. https://doi.org/10.2214/ajr.132.1.101.CrossRefPubMed

Jensen SR, Luttenegger TJ. Wire localization of nonpalpable breast lesions. Radiology. 1979;132(2):484–5. https://doi.org/10.1148/132.2.484.CrossRefPubMed

Kopans DB, DeLuca S. A modified needle-hookwire technique to simplify preoperative localization of occult breast lesions. Radiology. 1980;134(3):781. https://doi.org/10.1148/radiology.134.3.7355235.CrossRefPubMed

Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol. 2002;178(5):1211–20. https://doi.org/10.2214/ajr.178.5.1781211.CrossRefPubMed

Chakedis JM, Tang A, Kuehner GE, et al. Implementation of intraoperative ultrasound localization for breast-conserving surgery in a large, integrated health care system is feasible and effective. Ann Surg Oncol. 2021;28(10):5648–56. https://doi.org/10.1245/s10434-021-10454-8.CrossRefPubMedPubMedCentral

Ahmed M, Douek M. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat. 2013;140(3):435–46. https://doi.org/10.1007/s10549-013-2639-2.CrossRefPubMed

Postma EL, Koffijberg H, Verkooijen HM, Witkamp AJ, van den Bosch MA, van Hillegersberg R. Cost-effectiveness of radioguided occult lesion localization (ROLL) versus wire-guided localization (WGL) in breast conserving surgery for nonpalpable breast cancer: results from a randomized controlled multicenter trial. Ann Surg Oncol. 2013;20(7):2219–26. https://doi.org/10.1245/s10434-013-2888-7.CrossRefPubMed

Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8(9):711–5. https://doi.org/10.1007/s10434-001-0711-3.CrossRefPubMed

Lovrics PJ, Goldsmith CH, Hodgson N, et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann Surg Oncol. 2011;18(12):3407–14. https://doi.org/10.1245/s10434-011-1699-y.CrossRefPubMed

10.

Klein RL, Mook JA, Euhus DM, et al. Evaluation of a hydrogel based breast biopsy marker (HydroMARK(R) as an alternative to wire and radioactive seed localization for non-palpable breast lesions. J Surg Oncol. 2012;105(6):591–4. https://doi.org/10.1002/jso.22146.CrossRefPubMed

11.

Pavlicek W, Walton HA, Karstaedt PJ, Gray RJ. Radiation safety with use of I-125 seeds for localization of nonpalpable breast lesions. Acad Radiol. 2006;13(7):909–15. https://doi.org/10.1016/j.acra.2006.03.017.CrossRefPubMed

12.

Kasales C. Wireless localization of breast lesions: an update. Semin Roentgenol. 2022;57(2):139–44. https://doi.org/10.1053/j.ro.2021.12.007.CrossRefPubMed

13.

Kedrzycki MS, Elson DS, Leff DR. Guidance in breast-conserving surgery: tumour localization versus identification. Br J Surg. 2022. https://doi.org/10.1093/bjs/znac409.CrossRefPubMedCentral

14.

Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses. https://ClinicalTrials.gov/show/NCT04604561

15.

Davey MG, O’Donnell JPM, Boland MR, et al. Optimal localization strategies for non-palpable breast cancers – a network meta-analysis of randomized controlled trials. Breast. 2022;62:103–13. https://doi.org/10.1016/j.breast.2022.02.004.CrossRefPubMedPubMedCentral

16.

Garzotto F, Comoretto RI, Michieletto S, et al. Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: a systematic review and meta-analysis. Breast. 2021;58:93–105. https://doi.org/10.1016/j.breast.2021.04.007.CrossRefPubMedPubMedCentral

17.

Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis. J Surg Oncol. 2012;105(8):852–8. https://doi.org/10.1002/jso.23016.CrossRefPubMed

18.

Wang GL, Tsikouras P, Zuo HQ, et al. Radioactive seed localization and wire guided localization in breast cancer: a systematic review and meta-analysis. J BUON Jan-Feb. 2019;24(1):48–60.

19.

Franceschini G, Mason EJ, Grippo C, et al. Image-guided localization techniques for surgical excision of non-palpable breast lesions: an overview of current literature and our experience with preoperative skin tattoo. J Pers Med. 2021. https://doi.org/10.3390/jpm11020099.CrossRefPubMedPubMedCentral

20.

Mango V, Ha R, Gomberawalla A, Wynn R, Feldman S. Evaluation of the SAVI SCOUT surgical guidance system for localization and excision of nonpalpable breast lesions: a feasibility study. AJR Am J Roentgenol. 2016;207(4):W69–72. https://doi.org/10.2214/AJR.15.15962.CrossRefPubMed

21.

Baker JL, Haji F, Kusske AM, et al. SAVI SCOUT(R) localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Breast Cancer Res Treat. 2022;191(1):107–14. https://doi.org/10.1007/s10549-021-06416-z.CrossRefPubMed

22.

Ahmed M, Douek M. Radioactive seed localisation (RSL) in the treatment of non-palpable breast cancers: systematic review and meta-analysis. Breast. 2013;22(4):383–8. https://doi.org/10.1016/j.breast.2013.04.016.CrossRefPubMed

23.

DiNome ML, Kusske AM, Attai DJ, Fischer CP, Hoyt AC. Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery. Breast Cancer Res Treat. 2019;175(1):165–70. https://doi.org/10.1007/s10549-019-05143-w.CrossRefPubMed

24.

Kasem I, Mokbel K. Savi Scout(R) radar localisation of non-palpable breast lesions: systematic review and pooled analysis of 842 cases. Anticancer Res. 2020;40(7):3633–43. https://doi.org/10.21873/anticanres.14352.CrossRefPubMed

25.

Lee MK, Sanaiha Y, Kusske AM, et al. A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers. Breast Cancer Res Treat. 2020;182(2):299–303. https://doi.org/10.1007/s10549-020-05707-1.CrossRefPubMed

26.

McGhan LJ, McKeever SC, Pockaj BA, et al. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol. 2011;18(11):3096–101. https://doi.org/10.1245/s10434-011-1910-1.CrossRefPubMed

27.

McGugin C, Spivey T, Coopey S, et al. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions. Breast Cancer Res Treat. 2019;177(3):735–9. https://doi.org/10.1007/s10549-019-05355-0.CrossRefPubMed

28.

Micha AE, Sinnett V, Downey K, et al. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions. Breast Cancer. 2021;28(1):196–205. https://doi.org/10.1007/s12282-020-01149-1.CrossRefPubMed

29.

Murphy E, Quinn E, Stokes M, et al. Initial experience of magnetic seed localization for impalpable breast lesion excision: first 100 cases performed in a single Irish tertiary referral centre. Surgeon. 2022;20(3):e36–42. https://doi.org/10.1016/j.surge.2021.02.010.CrossRefPubMed

30.

Murphy JO, Moo TA, King TA, et al. Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience. Ann Surg Oncol. 2013;20(13):4121–7. https://doi.org/10.1245/s10434-013-3166-4.CrossRefPubMedPubMedCentral

31.

Patel SN, Mango VL, Jadeja P, et al. Reflector-guided breast tumor localization versus wire localization for lumpectomies: a comparison of surgical outcomes. Clin Imaging. 2018;47:14–7. https://doi.org/10.1016/j.clinimag.2017.07.020.CrossRefPubMed

32.

Rarick J, Kimler BF, Tawfik O. Comparison of margin status and lesional size between radioactive seed localized vs conventional wire localized breast lumpectomy specimens. Ann Diagn Pathol. 2016;21:47–52. https://doi.org/10.1016/j.anndiagpath.2016.01.003.CrossRefPubMed

33.

Rhee D, Pockaj B, Wasif N, et al. Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies. Am J Surg. 2018;215(1):151–4. https://doi.org/10.1016/j.amjsurg.2017.07.019.CrossRefPubMed

34.

Srour MK, Kim S, Amersi F, Giuliano AE, Chung A. Comparison of wire localization, radioactive seed, and Savi scout((R)) radar for management of surgical breast disease. Breast J. 2020;26(3):406–13. https://doi.org/10.1111/tbj.13499.CrossRefPubMed

35.

Srour MK, Kim S, Amersi F, Giuliano AE, Chung A. Comparison of multiple wire, radioactive seed, and Savi Scout((R)) radar localizations for management of surgical breast disease. Ann Surg Oncol. 2021;28(4):2212–8. https://doi.org/10.1245/s10434-020-09159-1.CrossRefPubMed

36.

Tingen JS, McKinley BP, Rinkliff JM, Cornett WR, Lucas C. Savi Scout radar localization versus wire localization for breast biopsy regarding positive margin, complication, and reoperation rates. Am Surg. 2020;86(8):1029–31. https://doi.org/10.1177/0003134820939903.CrossRefPubMed

37.

Wazir U, Kasem I, Michell MJ, et al. Reflector-guided localisation of non-palpable breast lesions: a prospective evaluation of the SAVI SCOUT((R)) system. Cancers. 2021. https://doi.org/10.3390/cancers13102409.CrossRefPubMedPubMedCentral

38.

Zacharioudakis K, Down S, Bholah Z, et al. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study. Eur J Surg Oncol. 2019;45(11):2016–21. https://doi.org/10.1016/j.ejso.2019.06.035.CrossRefPubMed

39.

Jordan RM, Rivera-Sanchez L, Kelley K, et al. The impact of an electromagnetic seed localization device versus wire localization on breast-conserving surgery: a matched-pair analysis. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13366-x.CrossRefPubMed

Titel: Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions
verfasst von: Nicholas T. Champion, MD
Blaise Mooney, MD
Youngchul Kim, PhD
Junmin Whiting, PhD
Weihong Sun, MD, MS
John Kiluk, MD
Brian Czerniecki, MD, PhD
Susan Hoover, MD
Marie Catherine Lee, MD
Publikationsdatum: 08.08.2023
Verlag: Springer International Publishing
Erschienen in: Annals of Surgical Oncology / Ausgabe 12/2023
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-023-13976-5

Neu im Fachgebiet Chirurgie

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Patients and Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2023

Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis

Development and Validation of PET/CT-Based Nomogram for Preoperative Prediction of Lymph Node Status in Esophageal Squamous Cell Carcinoma

Routine Use of a Standardized Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report

ASO Visual Abstract: Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis of Ductal Carcinoma In Situ

Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis

Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I–II Hepatocellular Carcinoma

Update Chirurgie